Institutional Ownership Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 1.73 Million shares, which have been reported (via 13F filing form) to have a value of $4.63 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
983,063
shares
|
$2.63 Million
0.0% of portfolio
|
Q2 2024
Added 38.51%
|
|
|
Oup Management Co., LLC
|
Nov 09, 2023 Q3 2023 |
603,762
shares
|
$1.62 Million
18.43% of portfolio
|
Q4 2021
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
75,674
shares
|
$202,806
0.0% of portfolio
|
Q1 2025
Added 12.67%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
40,047
shares
|
$107,325
0.0% of portfolio
|
Q4 2023
Added 10.29%
|
|
|
Kovitz Investment Group Partners, LLC
|
Aug 14, 2025 Q2 2025 |
24,210
shares
|
$64,882
0.0% of portfolio
|
Q2 2025
Reduced 8.69%
|
|
|
Alamea Verwaltungs Gmb H
Edison, NJ |
Aug 14, 2025 Q2 2025 |
204
shares
|
$546
0.0% of portfolio
|
Q1 2025
New holding
|